Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of NF-κB signaling pathway

Mol Immunol. 2012 Feb;50(1-2):117-23. doi: 10.1016/j.molimm.2011.12.012. Epub 2012 Jan 20.

Abstract

Monocyte-endothelial interactions play an important role in inflammatory diseases and may modulate vasculopathy in sickle cell disease, a disorder with an important inflammatory component. We co-incubated normal and sickle monocytes, lymphocytes and TNF-α with pulmonary microvascular and arterial endothelial cells and compared the expression of genes coding for adhesion molecules and cytokines that might contribute to sickle vasoocclusion. Monocyte-endothelial cell co-incubation resulted in up-regulation of L-selectin, E-selectin, VCAM-1, ICAM-1, MCP-1, MMP-1, TNF-α, IL-6 and IL-1β and down-regulation of eNOS. Lymphocyte-endothelial cell co-incubations, induced similar effects restricted to pulmonary artery endothelial cells. TNF-α had similar effects on the endothelial cells as monocytes did, however monocyte induced gene expression in endothelial cells was not TNF-α dependent but was regulated through the NF-κB pathway. Sickle monocytes lead to altered expression of L-selectin, MCP-1 and MMP-1 in pulmonary vascular endothelium when compared with normal monocytes. The gene expression changes we observed could reflect pathological events of sickle vasoocclusion.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / genetics
  • Cell Adhesion Molecules / genetics
  • Cell Communication
  • Cell Line
  • Cells, Cultured
  • Coculture Techniques
  • Cytokines / genetics
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Gene Expression / drug effects
  • Gene Expression Profiling*
  • Humans
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism
  • Monocytes / drug effects
  • Monocytes / metabolism*
  • NF-kappa B / genetics*
  • Nitric Oxide Synthase Type III / genetics
  • Pulmonary Artery / cytology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / genetics*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Cell Adhesion Molecules
  • Cytokines
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide Synthase Type III